Related Experiment Video
Updated: Feb 23, 2026
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Successful plasmapheresis in Bickerstaff's brain stem encephalitis associated with anti-GQ1b antibody
1Department of Biochemistry, Faculty of Medicine, Tokyo Medical and Dental University, Japan.
Patients with Guillain-Barré syndrome (GBS) and Fisher's syndrome (FS) benefit from plasmapheresis. Specific treatments, however, have yet to be established for Bickerstaff's brain stem encephalitis (BBE). We showed earlier that sera from BBE patients, as well as from patients with FS and GBS with ophthalmoplegia, have autoantibody to GQ1b ganglioside in the acute phase of the disease. We report 2 BBE patients who had high IgG anti-GQ1b antibody titers and were treated successfully with plasmapheresis.
Patients with Guillain-Barré syndrome (GBS) and Fisher's syndrome (FS) benefit from plasmapheresis. Specific treatments, however, have yet to be established for Bickerstaff's brain stem encephalitis (BBE). We showed earlier that sera from BBE patients, as well as from patients with FS and GBS with ophthalmoplegia, have autoantibody to GQ1b ganglioside in the acute phase of the disease. We report 2 BBE patients who had high IgG anti-GQ1b antibody titers and were treated successfully with plasmapheresis.
